rs5982

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_000129.4(F13A1):​c.1694C>T​(p.Pro565Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.214 in 1,613,906 control chromosomes in the GnomAD database, including 38,795 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. P565P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.20 ( 3094 hom., cov: 32)
Exomes 𝑓: 0.22 ( 35701 hom. )

Consequence

F13A1
NM_000129.4 missense

Scores

15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 2.58

Publications

46 publications found
Variant links:
Genes affected
F13A1 (HGNC:3531): (coagulation factor XIII A chain) This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is comprised only of 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion. [provided by RefSeq, Jul 2008]
F13A1 Gene-Disease associations (from GenCC):
  • factor XIII, A subunit, deficiency of
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
  • congenital factor XIII deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069898665).
BP6
Variant 6-6174633-G-A is Benign according to our data. Variant chr6-6174633-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 255183.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.334 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
F13A1NM_000129.4 linkc.1694C>T p.Pro565Leu missense_variant Exon 12 of 15 ENST00000264870.8 NP_000120.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
F13A1ENST00000264870.8 linkc.1694C>T p.Pro565Leu missense_variant Exon 12 of 15 1 NM_000129.4 ENSP00000264870.3

Frequencies

GnomAD3 genomes
AF:
0.196
AC:
29762
AN:
151976
Hom.:
3090
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.159
Gnomad AMI
AF:
0.203
Gnomad AMR
AF:
0.136
Gnomad ASJ
AF:
0.219
Gnomad EAS
AF:
0.307
Gnomad SAS
AF:
0.347
Gnomad FIN
AF:
0.213
Gnomad MID
AF:
0.263
Gnomad NFE
AF:
0.209
Gnomad OTH
AF:
0.196
GnomAD2 exomes
AF:
0.212
AC:
53317
AN:
251446
AF XY:
0.223
show subpopulations
Gnomad AFR exome
AF:
0.151
Gnomad AMR exome
AF:
0.0951
Gnomad ASJ exome
AF:
0.224
Gnomad EAS exome
AF:
0.321
Gnomad FIN exome
AF:
0.207
Gnomad NFE exome
AF:
0.206
Gnomad OTH exome
AF:
0.207
GnomAD4 exome
AF:
0.216
AC:
315131
AN:
1461812
Hom.:
35701
Cov.:
40
AF XY:
0.219
AC XY:
159585
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.154
AC:
5152
AN:
33480
American (AMR)
AF:
0.101
AC:
4530
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.221
AC:
5776
AN:
26134
East Asian (EAS)
AF:
0.302
AC:
11970
AN:
39700
South Asian (SAS)
AF:
0.328
AC:
28282
AN:
86258
European-Finnish (FIN)
AF:
0.203
AC:
10851
AN:
53420
Middle Eastern (MID)
AF:
0.253
AC:
1456
AN:
5766
European-Non Finnish (NFE)
AF:
0.210
AC:
233539
AN:
1111942
Other (OTH)
AF:
0.225
AC:
13575
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
15070
30140
45209
60279
75349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8238
16476
24714
32952
41190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.196
AC:
29785
AN:
152094
Hom.:
3094
Cov.:
32
AF XY:
0.199
AC XY:
14758
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.159
AC:
6586
AN:
41514
American (AMR)
AF:
0.135
AC:
2069
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.219
AC:
760
AN:
3470
East Asian (EAS)
AF:
0.306
AC:
1579
AN:
5152
South Asian (SAS)
AF:
0.348
AC:
1674
AN:
4812
European-Finnish (FIN)
AF:
0.213
AC:
2252
AN:
10560
Middle Eastern (MID)
AF:
0.269
AC:
79
AN:
294
European-Non Finnish (NFE)
AF:
0.209
AC:
14187
AN:
67982
Other (OTH)
AF:
0.196
AC:
414
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1208
2416
3624
4832
6040
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
340
680
1020
1360
1700
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.203
Hom.:
7021
Bravo
AF:
0.182
TwinsUK
AF:
0.210
AC:
777
ALSPAC
AF:
0.198
AC:
765
ESP6500AA
AF:
0.158
AC:
697
ESP6500EA
AF:
0.210
AC:
1807
ExAC
AF:
0.216
AC:
26217
Asia WGS
AF:
0.281
AC:
978
AN:
3478
EpiCase
AF:
0.212
EpiControl
AF:
0.213

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 9920838, 11108652, 20384622) -

Oct 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Factor XIII, A subunit, deficiency of Benign:2
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.075
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
20
DANN
Benign
0.38
Eigen
Benign
-0.66
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.45
N
MetaRNN
Benign
0.0070
T
MetaSVM
Benign
-1.1
T
PhyloP100
2.6
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.31
N
REVEL
Benign
0.077
Sift
Benign
0.73
T
Sift4G
Benign
0.67
T
Vest4
0.036
MPC
0.23
ClinPred
0.012
T
GERP RS
5.8
gMVP
0.58
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5982; hg19: chr6-6174866; COSMIC: COSV53555780; API